Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: the scientific support for mammography screening.

Kopans DB.

Radiol Clin North Am. 2010 Sep;48(5):843-57. doi: 10.1016/j.rcl.2010.06.005. Review.

PMID:
20868889
2.

United States Preventive Services Task Force screening mammography recommendations: science ignored.

Hendrick RE, Helvie MA.

AJR Am J Roentgenol. 2011 Feb;196(2):W112-6. doi: 10.2214/AJR.10.5609.

PMID:
21257850
3.

The recent US preventive services task force guidelines are not supported by the scientific evidence and should be rescinded.

Kopans DB.

J Am Coll Radiol. 2010 Apr;7(4):260-4. doi: 10.1016/j.jacr.2009.12.008.

PMID:
20362940
4.
5.

Breast cancer screening: who should be included?

Miller AB.

J Gen Intern Med. 1990 Sep-Oct;5(5 Suppl):S19-22.

PMID:
2231059
6.

USPSTF screening recommendations for breast cancer: the potential impact on the African American community.

Martin N, Wingfield J.

J Health Care Poor Underserved. 2012 May;23(2 Suppl):91-7. doi: 10.1353/hpu.2012.0072.

PMID:
22643557
7.

Patient understanding of the revised USPSTF screening mammogram guidelines: need for development of patient decision aids.

Allen SV, Solberg Nes L, Marnach ML, Polga K, Jenkins SM, Files JA, Croghan IT, Ghosh K, Pruthi S.

BMC Womens Health. 2012 Oct 10;12:36. doi: 10.1186/1472-6874-12-36.

8.

Breast cancer screening: controversies and future directions.

Retsky M, Demicheli R, Hrushesky W.

Curr Opin Obstet Gynecol. 2003 Feb;15(1):1-8. Review.

PMID:
12544495
9.

Mammography in 40-year-old women: what difference does it make? The potential impact of the U.S. Preventative Services Task Force (USPSTF) mammography guidelines.

Shen N, Hammonds LS, Madsen D, Dale P.

Ann Surg Oncol. 2011 Oct;18(11):3066-71. doi: 10.1245/s10434-011-2009-4. Epub 2011 Aug 24.

PMID:
21863364
11.

Mammography screening for breast cancer: recommendation of the U.S. Preventive Services Task Force.

LeFevre ML, Calonge N, Dietrich AJ, Melnikow J.

Am Fam Physician. 2010 Sep 15;82(6):602, 609. No abstract available.

12.

Breast cancer screening. Interpreting new data for clinical practice.

Daly L.

Physician Assist. 1994 Oct;18(10):47-51, 56, 61-6. Review.

PMID:
10138304
13.
14.

The public's response to the U.S. Preventive Services Task Force's 2009 recommendations on mammography screening.

Squiers LB, Holden DJ, Dolina SE, Kim AE, Bann CM, Renaud JM.

Am J Prev Med. 2011 May;40(5):497-504. doi: 10.1016/j.amepre.2010.12.027.

PMID:
21496748
15.

Controversies in breast cancer screening.

Leitch AM.

Cancer. 1995 Nov 15;76(10 Suppl):2064-9. Review.

16.

[The effectiveness of population-based breast cancer screening programme].

Szynglarewicz B, Matkowski R, Kasprzak P, Kotowska J, Forgacz J, Pudełko M, Kornafel J.

Pol Merkur Lekarski. 2009 Feb;26(152):117-20. Polish.

PMID:
19388515
17.
18.

How to restore public trust about breast cancer screening? An opportunity to reinforce the need for further advances in science and technology and access to care.

Masood S.

Breast J. 2010 Jan-Feb;16(1):1-3. doi: 10.1111/j.1524-4741.2009.00893.x. No abstract available.

PMID:
20465597
19.

Re-examining current breast cancer screening: An analysis of the 2009 U.S. Preventive Services Task Force guidelines for breast cancer screening.

Beard C, Beard V.

Women Health. 2016;56(3):281-95. doi: 10.1080/03630242.2015.1088115. Epub 2015 Sep 11.

PMID:
26362522
20.

The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography.

Sharpe RE Jr, Levin DC, Parker L, Rao VM.

J Am Coll Radiol. 2013 Jan;10(1):21-4. doi: 10.1016/j.jacr.2012.07.008.

PMID:
23290669

Supplemental Content

Support Center